MIRM
Mirum Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$96.97
+11.42%Margins
Gross margin
71.9%
EBITDA margin
-174.3%
EBIT margin
-35.1%
Net margin
-186.3%
FCF margin
-56.5%
1668.1%
Return on equity
-88.0%
Return on assets
-24.8%
Return on invested capital
0.47x
Asset turnover
-$271.3M
Cash from operations
$5.72
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026